Sexually transmitted infections, sexual risk behaviours and perceived barriers to safe sex among drug users

Australian and New Zealand Journal of Public Health

Volumn 37, Issue 4, 2013, Pages 311-315

  Islam, M Mofizul ^a   Topp, Libby ^b   Conigrave, Katherine M ^c,d,e   Haber, Paul S ^d   White, Ann ^f   Day, Carolyn A ^d  

^a AUSTRALIAN NATIONAL UNIVERSITY   (Australia)

^b CANCER RESEARCH DIVISION   (Australia)

^c ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^d UNIVERSITY OF SYDNEY   (Australia)

^e UNIVERSITY OF NEW SOUTH WALES   (Australia)

^f SYDNEY LOCAL HEALTH DISTRICT   (Australia)

Author keywords

injecting drug users; low threshold healthcare; sexual risk behaviour; unprotected sex

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; AUSTRALIA; CONDOM; DRUG USE; FEMALE; HIGH RISK BEHAVIOR; HUMAN; INJECTING DRUG USERS; LOW-THRESHOLD HEALTHCARE; MALE; MIDDLE AGED; PREVALENCE; PSYCHOLOGICAL ASPECT; QUESTIONNAIRE; RISK FACTOR; SAFE SEX; SEXUAL BEHAVIOR; SEXUAL RISK BEHAVIOUR; SEXUALITY; SEXUALLY TRANSMITTED DISEASE; STATISTICAL MODEL; STATISTICS; SUBSTANCE ABUSE; UNPROTECTED SEX; UTILIZATION REVIEW; YOUNG ADULT; PSYCHOLOGY; SEXUALLY TRANSMITTED DISEASES; STATISTICS AND NUMERICAL DATA; UTILIZATION;

INJECTING DRUG USERS; LOW-THRESHOLD HEALTHCARE; SEXUAL RISK BEHAVIOUR; UNPROTECTED SEX;

ADOLESCENT; ADULT; AGED; AUSTRALIA; CONDOMS; DRUG USERS; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; PREVALENCE; QUESTIONNAIRES; RISK FACTORS; RISK-TAKING; SAFE SEX; SEXUAL BEHAVIOR; SEXUAL PARTNERS; SEXUALLY TRANSMITTED DISEASES; SUBSTANCE ABUSE, INTRAVENOUS; YOUNG ADULT;

EID: 84881519660     PISSN: 13260200     EISSN: None     Source Type: Journal    
DOI: 10.1111/1753-6405.12077     Document Type: Article

References (22)

1. Kral AH, Bluthenthal RN, Lorvick J, Gee L, Bacchetti P, Edlin BR,. Sexual transmission of HIV-1 among injection drug users in San Francisco, USA: risk-factor analysis. Lancet. 2001; 357 (9266): 1397-401.
2. Benotsch EG, Somlai AM, Pinkerton SD, Kelly JA, Ostrovski D, Gore-Felton C, et al,. Drug use and sexual risk behaviours among female Russian IDUs who exchange sex for money or drugs. Int J STD AIDS. 2004; 15 (5): 343-47.
3. Topp L,. Amphetamine-type stimulant use and risk-taking behaviours. In:, Allsop S, Lee N, editors. Perspectives on Amphetamine-type Stimulants. Melbourne (AUST): IP Communications; 2012. p. 69-82.
4. Strathdee SA,. Sexual HIV transmission in the context of injection drug use: implications for interventions. Int J Drug Policy. 2003; 14: 79-81.
5. Centers for Disease Control and Prevention. HIV Infection and HIV-Associated Behaviors Among Injecting Drug Users-20 Cities, United States, 2009. MMWR Morb Mortal Wkly Rep. 2012; 61 (8): 133-8.
6. Hwang LY, Ross MW, Zack C, Bull L, Rickman K, Holleman M,. Prevalence of sexually transmitted infections and associated risk factors among populations of drug abusers. Clin Infect Dis. 2000; 31 (4): 920-6.
7. Topp L, Day CA, Iversen J, Wand H, Maher L,. Fifteen years of HIV surveillance among people who inject drugs: the Australian Needle and Syringe Program Survey 1995-2009. AIDS. 2011; 25 (6): 835-42.
8. Bradshaw CS, Pierce LI, Tabrizi SN, Fairley CK, Garland SM,. Screening injecting drug users for sexually transmitted infections and blood borne viruses using street outreach and self collected sampling. Sex Transm Infect. 2005; 81 (1): 53-8.
9. Islam MM, Topp L, Iversen J, Day CA, Conigrave KM, Lisa Maher on behalf of the Collaboration of Australian NSPs. Healthcare utilisation and disclosure of injecting drug use among clients of Australia's needle and syringe programs. Aust N Z J Public Health. 2013; 37 (2): 148-54.
10. Rich JD, McKenzie M, Macalino GE, Taylor LE, Sanford-Colby S, Wolf F, et al,. A syringe prescription program to prevent infectious disease and improve health of injection drug users. J Urban Health. 2004; 81 (1): 122-34.
11. Islam MM, Grummett S, White A, Reid SE, Day CA, Haber PS,. A primary healthcare clinic in a needle syringe program may contribute to HIV prevention by early detection of incident HIV in an injecting drug user. Aust N Z J Public Health. 2011; 35 (3): 294-5.
12. Islam MM, Topp L, Conigrave KM, White A, Haber PS, Day CA,. Are primary health care centres that target injecting drug users attracting and serving the clients they are designed for? A case study from Sydney, Australia. Int J Drug Policy. 2012 July 18 PMID: 22818978.
13. Zhao M, Du J, Lu GH, Wang QY, Xu H, Zhu M, et al,. HIV sexual risk behaviors among injection drug users in Shanghai. Drug Alcohol Depend. 2006; 82 Suppl 1: S43-7.
14. Tyndall MW, Patrick D, Spittal P, Li K, O'Shaughnessy MV, Schechter MT,. Risky sexual behaviours among injection drugs users with high HIV prevalence: implications for STD control. Sex Transm Infect. 2002; 78 Suppl 1: i170-5.
15. Gyarmathy VA, Li N, Tobin KE, Hoffman IF, Sokolov N, Levchenko J, et al,. Unprotected sex in heterosexual partnerships of injecting drug users in st. Petersburg, Russia. AIDS Behav. 2011; 15 (1): 58-64.
16. Bogart LM, Kral AH, Scott A, Anderson R, Flynn N, Gilbert ML, et al,. Sexual risk among injection drug users recruited from syringe exchange programs in California. Sex Transm Dis. 2005; 32 (1): 27-34.
17. McCarthy M, Haddow LJ, Furner V, Mindel A,. Contact tracing for sexually transmitted infections in New South Wales, Australia. Sex Health. 2007; 4 (1): 21-5.
18. Rissel C, Bauman A, McLellan L, Lesjak M,. A 1994 population survey of the number of sexual partners over a 12-month period in New South Wales, Australia. Venereology. 2000; 13 (3): 111-17.
19. Rhodes T, Quirk A,. Where is the sex in harm reduction? Int J Drug Policy. 1995; 6: 76-81.
20. DesJarlais DC, Semaan S,. Interventions to reduce the sexual risk behaviour of injecting drug users. Int J Drug Policy. 2005; 16S; S58-S66.
21. Rehm J, Shield KD, Joharchi N, Shuper PA,. Alcohol consumption and the intention to engage in unprotected sex: systematic review and meta-analysis of experimental studies. Addiction. 2011; 107: 51-9.
22. Islam MM, Topp L, Conigrave KM, Beek Iv, Maher L, White A, et al,. The reliability of sensitive information provided by injecting drug users in a clinical setting: clinician-administered versus audio computer-assisted self-interviewing (ACASI). AIDS Care. 2012; 24 (12): 1496-503.